Literature DB >> 24045943

Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation.

Hairat Sabit1, Sairam S Mallajosyula, Alexander D MacKerell, Peter W Swaan.   

Abstract

Human apical sodium-dependent bile acid transporter (hASBT, SLC10A2) is responsible for intestinal reabsorption of bile acids and plays a key role in cholesterol homeostasis. We used a targeted and systematic approach to delineate the role of highly conserved transmembrane helix 2 on the expression and function of hASBT. Cysteine mutation significantly depressed transport activity for >60% of mutants without affecting cell surface localization of the transporter. All mutants were inaccessible toward chemical modification by membrane-impermeant MTSET reagent, strongly suggesting that transmembrane 2 (TM2) plays an indirect role in bile acid substrate translocation. Both bile acid uptake and sodium dependence of TM2 mutants revealed a distinct α-helical periodicity. Kinetic studies with conservative and non-conservative mutants of sodium sensitive residues further underscored the importance of Gln(75), Phe(76), Met(79), Gly(83), Leu(86), Phe(90), and Asp(91) in hASBT function. Computational analysis indicated that Asp(91) may coordinate with sodium during the transport cycle. Combined, our data propose that a consortium of sodium-sensitive residues along with previously reported residues (Thr(134), Leu(138), and Thr(149)) from TM3 may form the sodium binding and translocation pathway. Notably, residues Gln(75), Met(79), Thr(82), and Leu(86) from TM2 are highly conserved in TM3 of a putative remote bacterial homologue (ASBTNM), suggesting a universal mechanism for the SLC10A transporter family.

Entities:  

Keywords:  Drug Transport; Membrane Proteins; Membrane Transport; Site-directed Mutagenesis; Transporters

Mesh:

Substances:

Year:  2013        PMID: 24045943      PMCID: PMC3820874          DOI: 10.1074/jbc.M113.518555

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

2.  Helix bending in alamethicin: molecular dynamics simulations and amide hydrogen exchange in methanol.

Authors:  N Gibbs; R B Sessions; P B Williams; C E Dempsey
Journal:  Biophys J       Date:  1997-06       Impact factor: 4.033

3.  Transmembrane domain VII of the human apical sodium-dependent bile acid transporter ASBT (SLC10A2) lines the substrate translocation pathway.

Authors:  Naissan Hussainzada; Antara Banerjee; Peter W Swaan
Journal:  Mol Pharmacol       Date:  2006-08-09       Impact factor: 4.436

4.  Discovery of potent, nonsystemic apical sodium-codependent bile acid transporter inhibitors (Part 1).

Authors:  Samuel J Tremont; Len F Lee; Horng-Chih Huang; Bradley T Keller; Shyamal C Banerjee; Scott R Both; Andrew J Carpenter; Ching-Cheng Wang; Danny J Garland; Wei Huang; Claude Jones; Kevin J Koeller; Steve A Kolodziej; James Li; Robert E Manning; Matthew W Mahoney; Raymond E Miller; Deborah A Mischke; Nigam P Rath; Theresa Fletcher; Emily J Reinhard; Michael B Tollefson; William F Vernier; Grace M Wagner; Steve R Rapp; Judy Beaudry; Kevin Glenn; Karen Regina; Joe R Schuh; Mark E Smith; Jay S Trivedi; David B Reitz
Journal:  J Med Chem       Date:  2005-09-08       Impact factor: 7.446

Review 5.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Design of novel synthetic MTS conjugates of bile acids for site-directed sulfhydryl labeling of cysteine residues in bile acid binding and transporting proteins.

Authors:  Abhijit Ray; Antara Banerjee; Cheng Chang; Chandra M Khantwal; Peter W Swaan
Journal:  Bioorg Med Chem Lett       Date:  2006-01-04       Impact factor: 2.823

7.  Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types.

Authors:  Jeffery B Klauda; Richard M Venable; J Alfredo Freites; Joseph W O'Connor; Douglas J Tobias; Carlos Mondragon-Ramirez; Igor Vorobyov; Alexander D MacKerell; Richard W Pastor
Journal:  J Phys Chem B       Date:  2010-06-17       Impact factor: 2.991

8.  Putative irreversible inhibitors of the human sodium-dependent bile acid transporter (hASBT; SLC10A2) support the role of transmembrane domain 7 in substrate binding/translocation.

Authors:  Pablo M González; Naissan Hussainzada; Peter W Swaan; Alexander D Mackerell; James E Polli
Journal:  Pharm Res       Date:  2012-02-22       Impact factor: 4.200

Review 9.  Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.

Authors:  A F Hofmann; L R Hagey
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

10.  Conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT Interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton.

Authors:  Naissan Hussainzada; Tatiana Claro Da Silva; Eric Y Zhang; Peter W Swaan
Journal:  J Biol Chem       Date:  2008-05-28       Impact factor: 5.157

View more
  3 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

Review 2.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

3.  Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.

Authors:  Paresh P Chothe; Lindsay C Czuba; Robyn H Moore; Peter W Swaan
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-12-01       Impact factor: 3.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.